Trial Profile
Multicentre, Randomised, Double-Blind Study to Compare Stalevo [levodopa/carbidopa/entacapone] to Levodopa/Carbidopa in Patients With Parkinson's Disease Experiencing Symptoms of Early Wearing-Off.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Aug 2019
Price :
$35
*
At a glance
- Drugs Levodopa/carbidopa/entacapone (Primary) ; Levodopa/carbidopa
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms SEWOP
- Sponsors Orion Pharma
- 23 Jun 2019 Trial has been completed in Ireland, according to European Clinical Trials Database record.
- 17 Jun 2010 Results were reported at the 14th International Congress of Parkinson's Disease and Movement Disorders.
- 23 Jun 2009 Actual patient number (223) added as reported by ClinicalTrials.gov.